Zevra Therapeutics (ZVRA) FCF Margin (2019 - 2026)
Zevra Therapeutics' FCF Margin was 42.36% in Q2 2026, up 57.08 percentage points from -14.73% a year earlier and up 25.49 percentage points from the prior quarter.
Powered by 
Analysis
Zevra Therapeutics (ZVRA) FCF Margin (2019 - 2026) Analysis & Trends
On a trailing twelve-month basis, Zevra Therapeutics' FCF Margin was 23.96% through Jun 30, 2026, up 98.98 percentage points year-over-year; for FY2025, it was -2.28%, up 292.76 percentage points from FY2024.
- FCF Margin shows a five-year change of +12.56 percentage points (FY2020 to FY2025).
- In earlier years, FCF Margin was -295.04% in FY2024 (-171.84 pp), -123.20% in FY2023 (+61.92 pp), -185.12% in FY2022 (-221.20 pp) and 36.08% in FY2021 (+50.92 pp).
- The Q2 2026 figure marks the highest quarterly FCF Margin since Q2 2021.
- Compared with a year earlier, FCF Margin has increased for six straight quarters, with an average year-over-year change of +160.54 percentage points over the last eight quarters.
- The best year-over-year quarter for FCF Margin over five years was Q3 2025 (a gain of 506.22 percentage points); the worst was Q2 2022 (a drop of 454.69 percentage points).
- Per Business Quant data, ZVRA's FCF Margin in the three quarters before Q2 2026 was 16.86% (Q1 2026), 16.24% (Q4 2025) and 15.92% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 33.76% |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 28.82% |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 18.33% |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 26.96% |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 38.60% |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 6.55% |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 34.70% |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 44.00% |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 2.01% |
| 10 | Zevra Therapeutics | 612.56 Mn | -200.15 Mn | 38.18 Mn | 42.36% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 42.36% |
| Mar 31, 2026 | 16.86% |
| Dec 31, 2025 | 16.24% |
| Sep 30, 2025 | 15.92% |
| Jun 30, 2025 | -14.73% |
| Mar 31, 2025 | -40.79% |
| Dec 31, 2024 | -135.28% |
| Sep 30, 2024 | -490.30% |
| Jun 30, 2024 | -429.51% |
| Mar 31, 2024 | -471.97% |
| Dec 31, 2023 | -125.62% |
| Sep 30, 2023 | -165.80% |
| Jun 30, 2023 | -103.03% |
| Mar 31, 2023 | -128.27% |
| Dec 31, 2022 | -222.35% |
| Sep 30, 2022 | -230.55% |
| Jun 30, 2022 | -316.85% |
| Mar 31, 2022 | -90.01% |
| Dec 31, 2021 | -33.50% |
| Sep 30, 2021 | -139.13% |
API Access
Zevra Therapeutics FCF Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=fcf-margin&ticker=ZVRA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "fcf-margin", "ticker": "ZVRA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=fcf-margin&ticker=ZVRA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();